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Genomic imprinting mediated by DNA methylation restricts gene
expression to a single allele determined by parental origin and is
not generally considered to be under genetic or environmental
influence. Here, we focused on a differentially methylated region
(DMR) of approximately 1.9 kb that includes a 101-bp noncoding
RNA gene (nc886/VTRNA2-1), which is maternally imprinted in ∼75%
of humans. This is unlike other imprinted genes, which demonstrate
monoallelic methylation in 100% of individuals. The DMR includes
a CTCF binding site on the centromeric side defining the DMR bound-
ary and is flanked by a CTCF binding site on the telomeric side. The
centromeric CTCF binding site contains an A/C polymorphism
(rs2346018); the C allele is associated with less imprinting. The fre-
quency of imprinting of the nc886 DMR in infants was linked to
at least two nongenetic factors, maternal age at delivery and season of
conception. In a separate cohort, nc886 imprinting was associ-
ated with lower body mass index in children at 5 y of age. Thus,
we propose that the imprinting status of the nc886 DMR is “tun-
able” in that it is associated with maternal haplotype and prenatal
environment. This provides a potential mechanism for transmitting
information, with phenotypic consequences, from mother to child.
nc886 | VTRNA2-1 | polymorphic imprinting | epigenetic inheritance | DNA
methylation
Epigenome-wide association studies (EWASs) have used theInfinium Human Methylation 450 (HM450) array to identify
CpG sites that are differentially methylated in the DNA of in-
dividuals with differing phenotypes or diseases. Whereas most
studies are cross-sectional, some have sought to identify risk-
associated epigenetic marks that hold predictive value (1, 2). It
has been known for many years that genetic polymorphisms can
alter the frequency of DNA methylation, that is, they can alter
allele-specific DNA methylation (ASM) (3–5). DNA methyl-
ation is also associated with environmental perturbations (6–10):
for example, maternal and paternal exposures such as nutrition
and smoking are linked to the methylation states of CpG sites in
children (11–15).
Genomic imprinting is a type of ASM that is usually associated
with extended regions of parental-specific differentially methyl-
ated DNA [i.e., differentially methylated regions (DMRs)] and is
established in the gametes. Most of the approximately 100 imprin-
ted genes are monoallelically methylated at imprinting control re-
gions, where the gene is expressed from the unmethylated allele in
nearly all somatic tissues at a given developmental stage (16). The
exceptions include a small subset of genes that are imprinted in a
tissue- or isoform-specific manner, in brain and placenta, across
most individuals (16, 17). Importantly, unlike nonimprinted ASMs,
imprinting is not generally altered by genetic or nongenetic factors,
but is instead fixed in the population (18). Tight control of nearly
all imprinted genes across the human population is consistent
with the known importance of imprinting in regulating embryonic
development and neuronal function (19, 20). Disruptions in imprint-
ing can lead to human disorders, including Beckwith–Wiedemann,
Silver–Russel, Prader–Willi, and Angelman syndromes, all of
which have severe phenotypes impacting human growth and
development (21, 22).
Work performed in the P.A.J. and K.G. laboratories un-
covered a unique pattern of DNA methylation at the promoter
of a noncoding gene (nc886) whereby ∼75% of individuals
exhibited ASM and 25% were completely unmethylated (23).
Romanelli et al. (24) expanded on this finding to determine that this
region of DNA was polymorphically imprinted in a small sample
set. Before the conclusion that nc886 was polymorphically
imprinted, interindividual variation of imprinting status had been
reported only for placental-specific imprinted genes (25, 26).
Genomic imprinting is considered an all-or-none process, in
which DMRs on the maternal or paternal autosomes cause
monoallelic expression of the corresponding gene (27, 28). Im-
printing is commonly, but not always, established by silencing of
a single allele through DNA methylation (29). Maternally meth-
ylated imprinted genes are often associated with decreased size of
the developing fetus (30), whereas paternally expressed imprinted
genes are often associated with increased fetal weight (30). Im-
portantly, maternal exposures during pregnancy shift the percent-
age of DNA methylation or level of expression at imprinted genes,
primarily in the placenta (24, 31, 32). The best studied example
of genetic and environmental impacts on imprinted genes is that
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of the H19/IGF2 locus, where quantitatively small but additive
effects on levels of DNA methylation are seen (33). However, the
possibility that a parental cue from the environment or parental
genetics might shift the likelihood that genomic imprinting is
established in a human child has yet to be investigated.
Here, we studied the frequency of imprinting of a RNA po-
lymerase III-transcribed, noncoding RNA of 101 bp called nc886
(also referred to as VTRNA2-1), which can be silenced by DNA
methylation (23, 34). The complete nc886 sequence is found in
higher-order primates, although portions of it are present in
other mammals (SI Appendix, Fig. S1), which may indicate its
importance in primate evolution. ASM at the nc886 locus has
previously been studied and described as a human “metastable
epiallale,” which is an allele that shows epigenetic heterogeneity
in a population and is sensitive to environmental conditions (6,
35). However, an appreciation of the imprinting biology of this
locus has not been emphasized in prior studies. In this work, we
show that the region surrounding nc886 acts as an imprinted
DMR, as opposed to an intermediately methylated region. This
locus represents an instance of nonplacental polymorphic im-
printing in humans (24), and we show that variation of imprinting
in the population is associated with prenatal environment.
nc886 Is Part of a 1.9-kb Polymorphically Imprinted Region
Genomic imprinting occurs as parental-specific DMRs that tightly
regulate gene dosage (28). Nonimprinted ASMs, on the contrary,
depend on genomic context rather than parental origin, and on
local polymorphisms to affect CpG methylation states, which are
generally confined to shorter regions of DNA (3, 18, 36). We and
others have reported that nc886 expression is tightly regulated by
DNA methylation and that the nc886 locus shows polymorphic
imprinting in the human population when measured in peripheral
blood cells: approximately 75% of individuals worldwide are
monoallelically methylated and approximately 25% are bial-
lelically unmethylated at nc886 (23, 24, 34, 37).
We first used HM450 data to examine DNA methylation at
known imprinted DMRs (Fig. 1) (38). We calculated the vari-
ance of β-values in 26 imprinted DMRs that had a minimum of 5
HM450 probes by using data from peripheral blood of 2,664
European and Indian Asian subjects from the London Life Sci-
ences Prospective Population (LOLIPOP) study (39). We con-
firm that all imprinted DMRs investigated, except for probes
adjacent to nc886, have limited interindividual variance in this
cohort. This variance is much higher for nc886 than for other
included imprinted DMRs (Fig. 1A).
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Fig. 1. The nc886 DMR displays maternal polymorphic imprinting. (A) Populational variance for β-values in known imprinting control regions in peripheral
blood. Each dot corresponds to one CpG interrogated by an HM450 probe. Populational SDs (y-axis) are plotted for CpGs located in known imprinting DMRs
and nc886 (x-axis). Although all imprinting DMRs were examined, only imprinting control regions with more than five probes are included in the display and
sorted by the mean SD in the population. Imprinting control regions were retrieved from an earlier study (38). Probes with multimodal distribution of β-values
in the population are colored red. DNA methylation data were retrieved from the LOLIPOP study (39). (B, E, and H) DNA methylation data from the Infinium
HM450 BeadChip platform in 66 sperm samples (GEO accession numbers GSE47627 and GSE64096) for a paternally methylated DMR for the H19 gene (B), a
maternally methylated DMR for the PEG3 gene (E), and the nc886 DMR (H). Black lines point to the genomic location of each probe relative to the respective
DMR. (C, F, and I) Heat map of HM450 β-values from peripheral blood for H19 (C), PEG3 (F), and nc886 (I); data obtained from Wahl et al. (39). (D, G, and J)
β-Values of each sample are plotted for Infinium HM450 probes for H19 (D) PEG3 (G), and nc886 (J). HM450 probe IDs are provided in SI Appendix, Table S1.
Only probes with sequence mapped optimally are included.
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We chose to survey DNA methylation in more detail for
known imprinted loci containing a maternally methylated DMR
(PEG3), a paternally methylated DMR (H19), and, to expand our
window of investigation of nc886, a polymorphically imprinted
locus. We analyzed data from two independent studies of sperm
DNA (GSE47627 and GSE64096) and also peripheral blood
from the LOLIPOP study (39–41). The H19 DMR is fully meth-
ylated and the PEG3 DMR generally lacks DNA methylation in
66 sperm samples (Fig. 1 B and E, respectively). We found that the
nc886 locus and its flanking regions were unmethylated in all
sperm samples, similar to PEG3, a maternally methylated DMR
(Fig. 1H, dark blue), with partial methylation at a CTCF site on
the telomeric side. As expected of imprinted loci, we saw ∼50%
methylation in all peripheral blood samples forH19 and PEG3 (Fig.
1 C and F, green). For nc886 in peripheral blood, the majority of
samples showed approximately 50% methylation (green; Fig. 1I)
and the remainder showed methylation of nearly 0% (blue; Fig. 1I).
Based on these HM450 data, we defined the nc886 region as a
maternally derived DMR in the human population with boundaries
marked by two CTCF sites (spaced ∼3 kb apart; Fig. 1 H and I).
Consistent with previous work from Monk and coworkers (24),
whole-genome bisulfite sequencing data of various normal tissues
from The Cancer Genome Atlas (TCGA) (42) and BLUEPRINT
(43, 44) (SI Appendix, Fig. S2) better resolves the boundaries of
the nc886 DMR, which is 1,979 bp in size and includes the
nc886 locus. nc886 is overlapped by a CpG island, and the
DMR is bounded on the centromeric side by repetitive sequences
just outside a variably methylated CTCF site (Fig. 1 H and I) (24,
45). The nc886 DMR is flanked on the telomeric side by a CTCF
site that is unmethylated in peripheral blood (Fig. 1I).
We noted that three type II probes (cg04515200, cg13581155,
and cg11978884) within the nc886 DMR on the HM450 platform
displayed a consistent bias toward hypomethylation relative to
the rest of the probes in the DMR (Fig. 1H). We believe this is
inherent to the Infinium probe design because we could still
distinguish a separation in the methylation β-values for individuals
who had monoallelic methylation at these probes, and, based on
whole-genome bisulfite sequencing data, the three CpGs do not
appear biased from an averaged methylation level of 0.5 (Fig. 1I and
SI Appendix, Fig. S2). The high correlation of β-values among these
three probes and probes across the nc886 DMR also support the
idea that these three CpGs bear consistent methylation with the
entire DMR and that this DMR is acting as a contiguous unit
(SI Appendix, Fig. S3).
Imprinting is essentially dichotomous: DMRs are monoallelically
methylated or not. As such, methylation data cannot be considered
a continuous variable in which the methylation values of all of
the assayed DNA molecules are averaged. We reexamined the
LOLIPOP data set, taking this biology into account. For the H19
and PEG3 DMR, all data points were near a β-value of 0.5, as
expected (Fig. 1 D and G). However, for nc886, the dichotomous
nature of the data became clear, in that the nc886 DMR showed
β-values primarily at 50% or near 0% with the exception of the
three CpGs previously mentioned (Fig. 1J). Thus, by using the
data from the large cohort (39), we have confirmed the previous
observations that the nc886 DMR is polymorphically imprinted in
humans (23, 24).
An A/C SNP Is Associated with Local DNA Methylation Density
It has been unclear whether the polymorphic nature of im-
printing of the nc886 DMR is governed by genetic or nongenetic
factors, given the lack of evidence in the literature that genomic
imprinting can be associated with the local haplotype (5). Similar
to Van Baak et al. (35), we reanalyzed DNA methylation data
from twins generated by Grundberg et al. (46). We confirmed
their findings that monozygotic twins, but not dizygotic twins, are
concordant for DNA methylation across the nc886 DMR (SI
Appendix, Fig. S4), strongly suggesting that the nc886 DMR
could be influenced by genetic factors. The nc886 locus is located
within a haplotype block ranging in size from ∼5 kb to 35 kb,
depending on the population (SI Appendix, Fig. S5). The 2 kb
spanning the nc886 DMR has been examined for potentially
causal SNPs without success or with the conclusion that SNPs did
not impact DNA methylation (6, 23, 24, 37, 45). Given the
central role of CTCF in imprinting, we focused on an A/C SNP
(rs2346018; A allele frequency range, 31–45%; C allele fre-
quency range, 54–68%; from the 1000 Genomes Project) located
in the variably methylated centromeric CTCF binding site (36,
47, 48). By using the R package motifbreakR, we found that
having a C SNP “breaks” the CTCF binding motif of the cen-
tromeric CTCF site and could therefore impact the ability of
CTCF to bind its target (49). To determine if SNP status was
associated with local DNA methylation density, we analyzed
DNA methylation at the centromeric CTCF site and across the
nc886 locus in peripheral blood DNA of 31 cancer-free indi-
viduals by using bisulfite conversion followed by clonal se-
quencing (primer locations shown in Fig. 2A). Eight examples
are shown in Fig. 2B, with the data from the remaining 23 indi-
viduals shown in SI Appendix, Fig. S6. Clearly, the A and C alleles
can be densely methylated in homozygotes and heterozygotes, but
there was also sporadic methylation in predominantly methylated
or unmethylated DNA strands (Fig. 2B).
We chose to test the hypothesis that genetic background could
“tune” the likelihood that an individual displays imprinting at the
nc886 DMR, thereby switching from imprinted to not imprinted.
Examining data from heterozygous and homozygous individuals,
we determined that the A allele has higher average methylation
density than the C allele (Fig. 2C; P < 1 × 10−9). Furthermore,
the odds ratio that a clone of the centromeric CTCF site is fully
methylated in an individual with the A polymorphism (vs. C) was
2.86. These data demonstrate that DNA methylation of the cen-
tromeric CTCF site, 900 bp from nc886, correlates with a common
SNP, with an A allele more likely to be methylated than a C allele.
Given the role of CTCF in imprinting, the presence of the A allele
might directly alter the likelihood of establishing DNA methyl-
ation at the nc886 DMR through reduced sequence binding af-
finity of CTCF or other DNA-binding proteins (e.g., DNMTs,
ZFP57, Kaiso) (50, 51). Alternatively, the A allele might indirectly
impact imprinting through increased DNA methylation density,
and therefore binding affinity of CTCF (52) (see Fig. 5).
Linked DNA Methylation of the Centromeric CTCF Binding
Site and nc886
Previous work has shown that DNA methylation at the centro-
meric CTCF site serves as the boundary of ASM for the
nc886 region (24, 45). Because the entire 1.9-kb region between
the CTCF sites acts as a DMR (Fig. 1 and SI Appendix, Figs.
S2 and S3), we hypothesized that DNA methylation of the cen-
tromeric CTCF site, or of any region within the DMR, might
predict DNA methylation at nc886. Although other studies have
suggested that the entire region can be imprinted (23, 32), they
have not shown a lack of DNA methylation of this region in
sperm, as we have (Fig. 1H), and it is technically challenging to
show that DNA methylation is linked across a single DNA strand.
Fig. 2B shows clonal bisulfite sequencing analysis of genomic
DNA from individuals who have monoallelic methylation or no
methylation, as indicated by SNP status in the centromeric CTCF
site. We classified 50% methylation, representative of monoallelic
methylation at nc886, as being “1” and 0% methylation, or bial-
lelic lack of methylation, as being “0,” and modeled the data
against the percentage of DNA methylation at the centromeric
CTCF site for all 31 individuals (Fig. 2D). Lack of DNA methyl-
ation at the centromeric CTCF site was associated with a very low
probability of having DNA methylation at nc886. With increasing
density of DNA methylation at the centromeric CTCF site, the
probability of nc886 being classified as “imprinted” increased; thus,
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there was a strong positive correlation between DNA methylation
at the centromeric CTCF site and at nc886 (P < 0.0001; R2 = 0.77;
Fig. 2D). DNA methylation of the centromeric CTCF site there-
fore explains much of the variation in DNA methylation at
nc886. Although we were not able to sequence individual DNA
strands greater than 1 kb in length, these data and the high
correlation between β-values across the nc886 DMR (SI Ap-
pendix, Fig. S3) suggest that DNA methylation of this region is
indeed present on individual alleles (Fig. 2).
DNA Methylation of the Centromeric CTCF Binding Site Is
Maternally Derived
As summarized in SI Appendix, Table S2, previous studies ana-
lyzing SNPs have independently concluded that DNA methylation
across the nc886 region is not dependent on genetic context but is
maternally derived (23, 24, 37, 45). Additionally, when analyzing
HM450 data from sperm, we find that the nc886 DMR lacks DNA
methylation, indicating that methylation of this region is likely
maternally derived (Fig. 1H). To confirm that DNA methylation of
the centromeric CTCF site could be included in this region of
maternally derived methylation, we used parent–offspring trios in-
formative for the A/C SNP (rs2346018) and performed bisulfite
conversion and clonal sequencing. As shown in Fig. 3, DNA
methylation of the centromeric CTCF site was maternally derived.
Thus, the existing literature and the lack of DNA methylation across
the nc886 DMR in sperm (Fig. 1H), along with this result, supports
that imprinting of the nc886 DMR is not paternally derived.
Maternal Age and Nutrition Are Associated with the nc886
DMR
Recent EWAS studies have identified nc886 as a “metastable
epiallele” that is altered in the population and is dependent on
maternal nutritional status (6, 35, 53). However, these studies
did not consider the data in terms of the percentage of each
cohort demonstrating imprinting, which might account for the
biology. Therefore, we reanalyzed the results from three inde-
pendent studies in terms of percentage of each subpopulation that
exhibits imprinting to determine if the likelihood that an individ-
ual is called “imprinted” shifts in each experimental group (SI
Appendix, Fig. S7). To address global shifts in β-values introduced
by different methods used to preprocess the HM450 data or by
residual experimental batch effects, we applied unsupervised hi-
erarchical clustering, using the DNA methylation β-values from
the entire region to determine whether an individual had im-
printing at the nc886 DMR and whether this call is conclusive.
We used the valuable data from Silver et al. (6), who examined
DNA methylation in 114 children in Gambia conceived in the
rainy season (low-calorie, nutritionally rich) or dry season (high-
calorie, nutritionally poor). Hierarchical clustering identified
three groups of individuals, two of which showed the expected
dichotomy of being imprinted or not imprinted. The third clus-
ter, consisting of five children (4.4%) who had evidence of DNA
methylation in only approximately half of the probes in the nc886
DMR, was classified as inconclusive (SI Appendix, Figs. S7A and
S8B). When comparing imprinted individuals and nonimprinted
individuals, we found that season of conception was significantly
(P = 0.0417) associated with the frequency of imprinting of the
nc886 DMR in infants (Fig. 4). In this data set, we performed
likelihood ratio tests (LRTs) to adjust for available confounding
factors, including exposure to aflatoxin (a common foodborne
toxin in Africa) and sex. We found that neither variable was a
significant predictor of imprinting at nc886, and, after adjusting
for these factors, the significance of the season of conception
slightly improves (P = 0.03902). Thus, season of conception and,
by association, maternal nutrition, may contribute to “tuning”
the likelihood that an individual has imprinting at the nc886
A C
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Fig. 2. An A polymorphism (rs2346018) is associated with higher local DNA methylation density at the centromeric CTCF site, which has a strong positive
correlation to DNA methylation at nc886. (A) Diagram of the nc886 DMR. Black arrows indicate primer locations for bisulfite sequencing in Figs. 2 and 3 and SI
Appendix, Fig. S6. (B) Bisulfite conversion and clonal sequencing of genomic DNA from white blood cells of eight individuals at the centromeric CTCF site and
nc886. Asterisk indicates SNP location. (C) Percentage of CpGs methylated for each allele at the centromeric CTCF site in homozygotes and heterozygotes (n =
31; P < 1 × 10−9). (D) DNA methylation of the centromeric CTCF plotted against DNA methylation of nc886 as a discrete variable, with 0 being biallelically
unmethylated and 1 being monoallelically methylated (n = 31; P = 4.7 × 10−7). Gray ribbon represents 95% CI.
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DMR. Furthermore, recent analysis of a Scottish birth cohort
identified differential DNA methylation of nc886 in response to
folate supplementation during pregnancy (53).
The same hierarchical clustering analysis was performed on
data from Markunas et al. (54) for DNA methylation of the
nc886 DMR in children born to 855 mothers of various ages (SI
Appendix, Fig. S7 C and D). We found that children born to
mothers younger than 20 y had significantly less imprinting than
those born to older mothers (P = 0.0167; Fig. 4). After adjust-
ment for sex, maternal age is still significantly associated with
imprinting of the nc886 DMR (LRT P = 0.0281). Our data
suggest that teenage pregnancy is associated with a decreased
likelihood that a child will have imprinting at the nc886 DMR.
We replotted data from van Dijk et al. (55) in which HM450
analysis was performed on blood spots obtained from children at
birth. This study identified lack of imprinting at nc886 measured
at birth as being strongly associated with increased body mass
index (BMI) in children assessed at 5 y of age. Hierarchical clus-
tering of the nc886 DMR was used to define imprinted, not-
imprinted, and inconclusive groups, and BMI was analyzed as a
continuous variable (SI Appendix, Fig. S7 E and F). We confirmed
that imprinting of the nc886 DMR was associated with lower BMI
in children when analyzed as discrete quartiles (Fig. 4) and as a
continuous variable (χ2 test P = 1.75 × 10−3 and logistic regression
P = 1.94 × 10−3, respectively). We conclude that imprinting of the
nc886 DMR is associated with a lower childhood BMI. Collec-
tively, these three data sets demonstrate that maternal environ-
ment is linked to the establishment of imprinting across the nc886
DMR in children and that this epigenetic mark potentially impacts
human phenotypes later in life.
Finally, we calculated the percentage of each population,
across all samples, that exhibited imprinting (Fig. 4). When ex-
amining all samples from the BMI data set, we found that 76%
of individuals were imprinted and 24% were not imprinted at the
nc886 DMR, similar to the maternal age study and consistent
with our previous findings in which 75% of individuals were
imprinted and 25% were not (23). In the smallest data set, which
examined maternal nutrition in Gambia, we found 82% of the
population with imprinting. Whether this is a result of environ-
mental differences or discrepancies in the genetic makeup of
different populations needs to be investigated.
Discussion
We conclude that the nc886 DMR, when imprinted, is mater-
nally methylated, given our evidence that this region behaves as a
contiguous DMR that is not methylated in sperm (Fig. 1H). The
fact that the entire 1.9-kb nc886 DMR is subject to tunable
polymorphic imprinting has been largely overlooked, emphasizing
the need to scrutinize data obtained from the HM450 platform for
possible dichotomization. We find that some of the polymorphic
nature of the imprinting can be explained by local genetic makeup,
as measured by using an A/C SNP in the centromeric CTCF site.
The mechanism by which this polymorphism alters the likelihood
of imprinting is not completely clear but is possibly associated with
chromatin conformation variation triggered by CTCF binding,
given reports that CTCF binding sites are involved in genomic
imprinting (56–58). This possibility is supported by the observation
that mutations in CTCF binding sites in the XIST promoter alter
CTCF binding efficiency and choice of X chromosome inactiva-
tion (51). Additionally, the presence of a genetic influence is sup-
ported by the fact that monozygotic twins are found to be more
concordant in DNA methylation at the nc886DMR than dizygotic
twins (35). However, Van Baak et al. (35) concluded that DNA
methylation at nc886 could not be explained by genetics alone and
A B
Fig. 3. Maternal imprinting of the nc886 region extends to the centromeric CTCF site. Locus-specific bisulfite sequencing was performed on genomic DNA at
the centromeric CTCF site. Genomic DNA was isolated from benign lymphoblastoid cell lines derived from parent–offspring trios (mother, father, child; A and
B are representative of two different trios) of disease-free individuals, in which SNP status can be determined from the sequence. Two representative parent–
offspring trios are shown. Clones are sorted based first on SNP status and then on DNA methylation.
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Fig. 4. Maternal environment in utero impacts DNA methylation of nc886
in infants. HM450 data for the nc886 DMR was analyzed from three inde-
pendent studies of peripheral blood of infants at birth. Each group is sepa-
rated by the percentage of the population that is imprinted vs. not imprinted
based on hierarchical clustering. Individuals with inconclusive evidence of im-
printing have been removed from this analysis. Mat, maternal. *P < 0.05.
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classified it as a region of “epigenetic supersimilarity.” Although
our data provide high-resolution analysis of local DNA methyl-
ation in 31 individuals, a very recent paper by Zink et al. (37)
found no genetic polymorphisms associated with imprinting of
nc886 in an Icelandic population, suggesting a need for further
genotyping and concurrent DNA methylation analysis in indi-
viduals from different populations and environmental contexts.
We find that the frequency of imprinting of the nc886 DMR in
children is also associated with the mothers’ age and season of
conception, indicating parental environment as potentially an-
other mechanism for tuning the likelihood that the nc886 DMR
will be imprinted (6, 54). Furthermore, the frequency of im-
printing of the nc886 DMR at birth is maintained and is directly
associated with the BMI of children at the age of 5 y (55).
Collectively, these results suggest that genetic and environmental
factors may affect the establishment of imprinting of a DMR,
which is closely associated with human physiology (Fig. 5). Un-
fortunately, there are no known SNPs in nc886 that would allow
us to examine tissues for allele-specific expression. However, we
have shown that DNA methylation can silence transcription of
nc886, making it very likely that differential methylation of this
region is functionally important (23, 34).
A further understanding of causality from all of these obser-
vations will require an unraveling of potential biological roles of
nc886 or the nc886 DMR. nc886 has been variously described as
a regulator of the dsRNA-dependent protein kinase R (PKR) (23,
59–61) and Dicer (62). It was also suggested as a possible tumor
suppressor (63) or oncogene (64). Alternatively, some other ge-
netic or epigenetic factors within or around the 1.9-kb DMR se-
quence may be drivers of phenotypic effects associated with nc886.
Thus far, EWAS studies have primarily focused on variations in
DNA methylation levels without considering the essential role of
imprinting in human development as we have done here.
Methods
DNA Methylation Analysis of Illumina HM450 Data. Normalized β-values were
downloaded from Gene Expression Omnibus (GEO), with accession numbers
GSE47627 and GES64096 for sperm and GSE55763 for genomic DNA from
peripheral blood of 2,664 individuals assayed on the Infinium HM450 platform
(i.e., LOLIPOP data). Probes falling in the region chr5:135413937–135419936
(Genome Build GRCh37) were extracted, and their signals were visualized by
using the R package SeSAMe (10). Genomic features were extracted from the
University of California, Santa Cruz, Genome Browser. Probes annotated with
potential cross-hybridization issues and SNP bias were excluded according to
an earlier study (10, 65). This analysis was also performed on matched normal
tissues from the TCGA database, as shown in SI Appendix, Fig. S2.
Locus-Specific Bisulfite Sequencing Analysis of the Centromeric CTCF Site and
nc886. Genomic DNA isolated from white blood cells of disease-free indi-
viduals was obtained from the Van Andel Research Institute Pathology and
Biorepository Core. For trio analysis, the following DNA samples were
obtained from the National Human Genome Research Institute Sample Re-
pository for Human Genetic Research at the Coriell Institute for Medical
Research: HG00731, HG00732, HG00733, HG01938, HG01939, and HG01940.
Bisulfite conversion and clean-up of 2 μg of genomic DNA was performed by
using the EZ DNA Methylation Kit (Zymo Research) according to the man-
ufacturer’s protocol. Locus-specific PCR was performed by using primers
specific for bisulfite-converted DNA and PCR products cloned by using the
pGEM-T Easy vector and NEB 5-alpha–competent Escherichia coli (New
England Biolabs). Colonies were screened for positive inserts by PCR and
sequencing performed using the M13 promoter.
Statistical Analysis.
Determining whether SNP status is associated with DNA methylation in the
centromeric CTCF region. β-Binomial mixed-effects regression, weighted by
the number of CpG sites in a region (10 for SNP A, 11 for C), was used to
model data obtained from bisulfite sequencing and PCR via the R package
(version 3.4.3; https://www.r-project.org/) glmmTMB (66). A random in-
tercept for each individual was used to account for the paired heterozygous
and homozygous measures; a second random intercept was included to
account for DNA methylation of the nc886 region as determined by the
presence of at least 10% of clones being completely methylated. β-Binomial
was chosen because it is well-suited for modeling the binary methylated/
unmethylated status of each CpG in the region, but the probability of a
given site being methylated increases with each additional site methylated
in the region. An LRT confirmed that weighted β-binomial was a better fit
for these data than a weighted binomial, and Akaike information criterion
Fig. 5. Working model for polymorphic imprinting of the nc886 locus. All individuals we examined have the single paternally derived unmethylated allele at
the nc886 DMR. In 75% of the human population, the nc886 DMR is monoallelically methylated on the maternally derived allele (Bottom), with the remaining
25% having no methylation on either allele (Top). Here, we demonstrate that the presence of an A or C polymorphism in the centromeric CTCF binding site is
associated with local DNA methylation density in the nc886 DMR. We hypothesize that the presence of the A allele or increased DNA methylation density
reduces CTCF binding, allowing DNA methylation to spread into the DMR. We reanalyzed data from Silver et al. (6) and Markunas et al. (54) and found that
maternal age and season of conception contribute to the likelihood that a child will have imprinting at the nc886 DMR. Therefore, we propose that a
combination of maternal factors shifts the balance between imprinted and not-imprinted status in children, with downstream phenotypic consequences such
as BMI.
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and Bayesian information criterion showed this regression was better than
negative binomial regression.
Determining the correlation between DNA methylation at the centromeric CTCF and
nc886 regions. The percentage of DNA methylation was calculated for each
region analyzed by bisulfite conversion and sequencing, and the data were
analyzed via logistic regression. Bisulfite sequencing was used to estimate
DNA methylation in the centromeric CTCF and nc886 regions. Logistic re-
gression was used to determine whether the probability of nc886 being
methylated changed as the percentage of methylation of the CTCF region
increased. The reported P value was calculated by using an LRT. The mean
percent methylation of the centromeric CTCF site was estimated by using a
mixed-effects negative binomial regression via the R package glmmTMB
(66). Data were plotted as the mean change in probability per percent in-
crease of methylation in the centromeric CTCF, with a 95% confidence band.
Population Analysis of DNA Methylation at nc886 from Published Datasets. We
downloaded fromGEO InfiniumHM450 data from genomic DNA of infants in
studies of season of conception in Gambia (6) and maternal age at delivery
(54) with accession numbers GSE59592 and GSE82273, respectively. For the
childhood BMI study (55), the GEO Infinium HM450 data (accession no.
GSE103657) was not optimal because of technical effects introduced by
batch correction. Instead, the raw array data were renormalized, consistent
with the methods of the published study, and BMI measurement data were
accessed through the authors of the paper of van Dijk et al. (55).
Based on bisulfite sequencing analysis (SI Appendix, Fig. S6), which pro-
vides single-base resolution of individual DNA strands for DNA methylation,
and previous studies, we concluded that there are only two possibilities for
DNA methylation in this region: near 0% DNA methylation (biallelically
unmethylated) or near 50% DNA methylation (monoallelically methylated)
(6, 23, 24, 67). However, when data were plotted, it was clear that not all
individuals exhibited this expected dichotomy of 50% methylated or not
methylated (SI Appendix, Fig. S7). Upon further investigation, we found that
individuals who did not fit this dichotomy comprised a third cluster based on
hierarchical clustering via Manhattan distances. Therefore, we identified three
clusters of individuals, which we called imprinted, not imprinted, or incon-
clusive based on partial methylation readouts throughout the region (SI
Appendix, Fig. S7). To remain consistent with previously observed data, we
restricted our analyses to focus on the patients not in this third, inconsistent
cluster. Results without this restriction are reported in the SI Appendix.
Treating imprinting as the response variable, we applied logistic regression
by using the glm function in R. The season of conception, maternal age
(dichotomized by teenage pregnancy), and childhood BMI Z-scores were used
as the regressors of the three data sets, respectively. P values for the coef-
ficients were obtained by using a Wald test.
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